JC’s Scientific Advisory Board

CENTER FOR SPORTS, EXERCISE & MENTAL HEALTH, WESTERN UNIVERSITY HEALTH SCIENCES, POMONA, CALIFORNIA AND DEPARTMENT OF MOLECULAR BIOLOGY, ADElSON SCHOOL OF MEDICINE, ARIEL UNIVERSITY, ARIEL, ISRAEL.
(Psychiatric Genetics & Pharmacogenomics – EIC Current Psychopharmacology and CRC Press -Editor – BODY RECOMPOSITION: A Comprehensive and Metabolic Alternative to Weight Loss)

Kenneth Blum is a well-known American scientist recognized for his work related to psychopharmacology and psychiatric genetics. He received a B.Sc. degree in Pharmaceutical Science from Columbia University (NYC); a master’s in medicine from New Jersey College of Medicine (Rutgers); and a Ph.D. in Neuropharmacology from New York Medical College. He completed a genetics fellowship at the University of Colorado at Boulder.

He is the recipient of many honors and awards, including the Marquis Who’s Who – Distinguished Top Professional featured in the Wall Street Journal. Dr. Blum has published over 740 peer-reviewed articles, book chapters, and meeting abstracts, along with 19 books that have garnered over 18,000 citations and 185,000 reads worldwide. He is credited with the first genetic association of the Dopamine D2 receptor gene with severe alcoholism, published in JAMA, 1990, and is considered by some to be the Father of Psychiatric Genetics.

In 1995, Dr. Blum coined the term “Reward Deficiency Syndrome (RDS)” and developed the USA and foreign-patented “Genetic Addiction Risk Severity” (GARS) test. He has also developed patented pro-dopamine regulators in the USA and Europe, and his overall patent portfolio consists of 100 patents worldwide.

Dr. Blum is the Editor-in-Chief of several academic journals, including Current Psychopharmacology, Addiction Psychiatry, and Theranostic and Pharmacological Sciences. He also serves as Associate Editor for Frontiers in Psychiatry and Frontiers in Public Health, specifically in sections on Substance Use Disorder and Genes, Protein & Disease. He is a guest Editor-in-Chief on a collective for Psychology & Psychological Management and Cellular Molecular Neurobiology. Dr. Blum serves on the editorial boards of 23 peer-reviewed journals and is a regional editor for Current Pharmaceutical & Biotechnology.

Dr. Blum is also the founding President of the United Scientific Group, an academic publishing house. His work has been featured in major media outlets worldwide, and in 1990, his work on genetics was listed among the top 25 most important discoveries in science by Discovery Magazine. He is the recipient of NIH grants and has been awarded Lifetime Achievement Awards, distinguished Honorary Doctorates of Humane Letters, Life-time Honorary Professorship at ELTE Eötvös Loránd University in Hungary, and Distinguished Honorary Professorship at the Adelson School of Medicine, Ariel University, Israel.

Currently, besides faculty positions as an adjunct professor (Western University, University of Vermont, Wright School of Medicine), he is the Executive Chairman and CEO of TranspliceGen Therapeutics, Inc. Stanford University recognized him as one of the top 2% of scientists worldwide in 2023. Dr. Blum also serves on several scientific boards, including the Center for Advanced Spine Care of Southern Arizona, Cross-Cultural Research and Educational Institute, Awareness Integration Institute, Quiet Mind Foundation, and Sunder Foundation. Additionally, he serves as a scientific advisor for Electronic Waveform Lab, Victory Nutrition International, and Peak Logic.

Dr. Blum is a member of the Society of Brain Mapping & Therapeutics (SMBMT). Most recently, the International Research Awards on Neurology and Neuro Disorders recognized him with the “Best Researcher Award 2023.” Dr. Blum has been nominated for the KEIO Medical & Science Prize (the Japanese equivalent to the Nobel Prize) in 2024.

PROFESSOR EMERITA, UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE, DEPARTMENTS OF NEUROLOGY AND MOLECULAR AND CELLULAR PHARMACOLOGY (NEUROSCIENCE)

DEPARTMENT OF HEALTH SCIENCE, CALIFORNIA STATE UNIVERSITY AT LONG BEACH, LONG BEACH, CA, USA
AWARENESS INTEGRATION INSTITUTE, SAN CLEMENTE, CA, USA
(Author of “Intentional Parenting,” Hardcover – July 1, 2022, with Nicole Jafari and Eileen Manookian)
Originator of Awareness Integration Therapy

Dr. Foojan Zeine is an international speaker, author, and psychotherapist. She holds a Doctorate in Clinical Psychology and is a Licensed Marriage & Family Therapist. She obtained a graduate certificate in Human Behavior from the Harvard Extension School (HES). Dr. Zeine’s expertise lies in intimate relations and addictive behaviors, and she has extensive experience treating depression, anxiety, trauma, and domestic violence.

Dr. Zeine presents internationally and is a leading expert in online therapy. She has published numerous research articles in psychology and human behavior. She is the originator and author of Awareness Integration Theory (AIT), a multi-modality psychology and educational approach aimed at minimizing depression and anxiety while improving self-esteem and self-confidence. She founded the International Awareness Integration Institute, which conducts training workshops to educate and certify psychotherapists, coaches, and teachers in this approach. Additionally, she co-founded the “Foojan” app, which offers AIT to the public globally.

Dr. Zeine teaches AIT as a lecturer/professor at California State University, Long Beach, and Université Paris Cité. She is the author and co-author of six books and ten peer-reviewed journal publications. She hosts the “Inner Voice – A Heartfelt Chat with Dr. Foojan” podcast and is a guest speaker at many universities, including Harvard, MIT, UCLA, USC, UC Santa Barbara, Chicago University, and Cal State Long Beach.

Radio/Television Podcast Host
Research Interests: Neuroplasticity and self-identity

Prof. Dr. Bowirrat Abdalla is a Full Professor at the Adelson School of Medicine and the Department of Molecular Biology, Ariel University, Israel. He attained his M.D. from Rome University, “La Sapienza,” with excellence, and completed his residency in Clinical Neurology at Queen Square – National Institute of Neurology and Neurosurgery, London University, UK.

He received his Ph.D. in Neuroscience from Tel-Aviv University, Israel, also with excellence, and completed his postdoctoral studies in Human Genetics at Boston University School of Medicine, USA.

Prof. Bowirrat received his professorship in Psychiatry (Behavioral Neuroscience Department) from Boston University. He has published more than 180 manuscripts and 10 books and chapters in reputed journals and serves as an editorial board member of several prominent medical journals. He has received numerous international awards, including the Bruce S. Schoenberg International Award in Neuroepidemiology of Alzheimer’s Disease from the American Academy of Neurology, and in 2019, he was selected as “Professor of the Year” by the Venus International Foundation, India. In 2022, he received a certificate of Honorary Faculty Position from the Institute of Integrative OMICS and Applied Biotechnology, India.

Prof. Bowirrat’s research focuses on enhancing health outcomes and finding novel treatments for neurological, psychiatric, and neuroinflammatory diseases, addiction, and various genetic disorders. He is actively involved in academic research and teaching across different medical fields. He has been invited as a speaker at various national and international conferences and has received several awards, including the Best Lecturer in Neuroepidemiology from the American Academy of Neurology and the Second Boston Scientific Poster Award from Boston University School of Medicine. Prof. Bowirrat received a significant grant from the NIH – USA, totaling $1.2 million, to study and research neurodegeneration (1996-2002). He has also collaborated extensively with Prof. Kenneth Blum’s lab in California, USA, particularly on the underlying etiology of addiction, substance abuse, and genetic tests for the diagnosis, prevention, and treatment of addiction.

Contact Information:

• Affiliation: Adelson School of Medicine & Department of Molecular Biology, Ariel University, Ariel 40700, Israel
• Residency: 28 Meir Rutberg Street, Haifa, Israel
• Mobile: +972 54 6693763
• Fax: +972 4 6356133
• Email: bowirrat@gmail.com, abdallab@ariel.ac.il
• Website: Ariel University Bio
• ORCID: 0000-0001-8185-0688

DEPARTMENT OF PSYCHIATRY – HARVARD UNIVERSITY SCHOOL OF MEDICINE, CAMBRIDGE, MA., USA (Neuroscience & Pain Management – EIC-Journal Psychology Research & Behavioral Management)

Dr. Igor Elman, MD, is a Board-Certified Psychiatrist with a subspecialty certification in Addiction Psychiatry. He earned his medical degree from Ben-Gurion University. Following residency and fellowship training at the Albert Einstein College of Medicine in New York, the National Institute of Mental Health, and Massachusetts General Hospital, Dr. Elman has been on the faculty of Harvard Medical School for 20 years.

He has held two Professor and Chair positions in the Department of Psychiatry at the Wright State University Boonshoft School of Medicine and Cooper Medical School of Rowan University. Dr. Elman serves as the Editor-in-Chief for the Journal of Psychology Research and Behavior Management and as the Special Issues Editor for Psychiatry Research.

Dr. Elman’s broad research interests focus on understanding the interplay between stress, reward, and metabolic systems and their impact on neuropsychiatric and medical disorders, including addiction, post-traumatic stress disorder, schizophrenia, obesity, and pain.

DEPARTMENT OF PHARMACEUTICAL SCIENCES, TEXAS SOUTHERN UNIVERSITY COLLEGE OF PHARMACY, HOUSTON, TX, USA (Microbiome Research and CRC Press – Editor – BODY RECOMPOSITION: A Comprehensive and Metabolic Alternative to Weight Loss)

Dr. Debasis Bagchi received his Ph.D. in Medicinal Chemistry in 1982. He is the Director of Innovation & Clinical Affairs at Dr. Herbs LLC, Concord, CA; an Adjunct Professor in the College of Pharmacy & Health Sciences at Texas Southern University, Houston, TX; an Adjunct Faculty member in the Department of Biology at Adelphi University, Garden City, NY, where he is the Course Director of Neurotoxicology (BIO 585); and an Adjunct Faculty member in the Department of Psychology at the Gordon F. Derner School of Psychology, Adelphi University, Garden City, NY, where he is the Course Co-Director of the Integrative Neuroscience Seminar (PIA395-001).

Dr. Bagchi is a former Professor in the Department of Pharmacological and Pharmaceutical Sciences at the University of Houston College of Pharmacy, Houston, TX. He served as the Chief Scientific Officer at Cepham Inc., Belmont, NJ, from June 2013 to December 2018, and as the Director of Scientific Affairs at VNI Inc., Bonita Springs, FL, from January 2019 to January 2023. He was the Senior Vice President of Research & Development at InterHealth Nutraceuticals Inc., Benicia, CA, from 1998 to February 2011, and the Director of Innovation and Clinical Affairs at Iovate Health Sciences, Oakville, ON, until June 2013.

Dr. Bagchi received the Master of American College of Nutrition Award in October 2010, became a Fellow of ISNFF in 2021, and was awarded a Fellowship of the Royal Society of Medicine (FRSM) in 2022. He is the past Chairman of the International Society of Nutraceuticals and Functional Foods (ISNFF), past President of the American College of Nutrition, Clearwater, FL, and past Chair of the Nutraceuticals and Functional Foods Division of the Institute of Food Technologists (IFT), Chicago, IL. He is serving as a Distinguished Advisor at the Japanese Institute for Health Food Standards (JIHFS), Tokyo, Japan. Dr. Bagchi is a member of the Study Section and Peer Review Committee of the National Institutes of Health (NIH), Bethesda, MD.

Dr. Bagchi has published 448 papers in peer-reviewed journals, authored 48 books, and holds 20 patents. He is a member of various professional societies, including the Society of Toxicology, the New York Academy of Sciences, the Nutrition Research Academy, and the TCE Stakeholder Committee of the Wright-Patterson Air Force Base, OH. He serves as an Associate Editor for the Journal of Functional Foods, the Journal of the American College of Nutrition, and the Archives of Medical and Biomedical Research, and is on the editorial boards of numerous peer-reviewed journals, including Antioxidants & Redox Signaling, Cancer Letters, Food & Nutrition Research, Toxicology Mechanisms and Methods, and The Original Internist.

Member of the Editorial Boards:

• Journal of the American College of Nutrition (Associate Editor)
• Journal of Functional Foods (Past Associate Editor)
• American Journal of Biopharmacy and Pharmaceutical Sciences (Associate Editor)
• Food & Nutrition Research
• Toxicology Mechanisms and Methods
• Antioxidants & Redox Signaling

Fellow/Member of Professional Societies:

• Master of the American College of Nutrition
• Fellow of the Royal Society of Medicine
• American College of Nutrition
• International Society of Nutraceutical and Functional Foods (ISNFF)
• Society of Toxicology
• New York Academy of Sciences
• American Institute of Chemical Engineers

List of Publications/Patents/Books:

• Peer-Reviewed Publications: 448
  Google Scholar (Citation 35334; h-index 89; i10-index 279)
  ResearchGate
• Patents: 20
  Justia Patents
• Books Edited: 46 (Elsevier/Academic Press; CRC Press/Taylor & Francis; Wiley-Interscience)

DEPARTMENT OF PSYCHIATRY, CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE, CLEVELAND, OH, USA

Dr. Rajendra D. Badgaiyan is a Professor of Psychiatry at the University of Texas Health San Antonio. After completing his psychiatry residency training at Harvard Medical School, Dr. Badgaiyan joined the faculties of Harvard Medical School, the State University of New York at Buffalo, and the University of Minnesota. He also served as Professor of Psychiatry and Chairman of the Department at the hospital affiliated with the Icahn School of Medicine at Mount Sinai, New York; Chief of Psychiatry at the South Texas Healthcare System in San Antonio, TX; and Chairman of the Psychiatry Department at Case Western Reserve University, Cleveland.

Dr. Badgaiyan developed a novel neurotransmitter imaging technique for the detection, mapping, and quantification of neurotransmitters released in the live human brain during mental activities. Using this technique, he studies the dopaminergic control of conscious and nonconscious cognition and behavior and seeks to understand the neuropathology of psychiatric conditions.

He has received several prizes and awards for his research, including the prestigious Solomon Prize from Harvard Medical School and the BK Anand National Research Prize in India. His research is funded by the National Institutes of Health, the Department of Veterans’ Affairs, the Dana Foundation, and other agencies. Dr. Badgaiyan has published over 300 research papers and book chapters. He is also the author of the book titled Neuroscience of the Nonconscious Mind (Elsevier/Academic Press).

DEPARTMENT OF MEDICINE, UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE, BALTIMORE, MD, USA
Former Chief, Medical Consequences Branch, NIDA (Retired)

Currently, Dr. Jag Khalsa serves as an Adjunct Professor at the George Washington University School of Medicine and the Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland. He is also a Special Volunteer at the National Institute on Drug Abuse (NIDA), NIH. Dr. Khalsa retired on October 31, 2017, after 30 years as the Chief of the Medical Consequences of Drug Abuse and Infections Branch, NIDA, NIH, DHHS.

With over 50 years of experience in drug research, Dr. Khalsa was responsible for developing and administering a national and international program of clinical research on the medical and health consequences of drug abuse and co-occurring infections (HIV, HCV, and others). Prior to joining NIDA in 1987, he served for approximately 10 years as a pharmacologist/toxicologist assessing the safety (carcinogenic/teratogenic) of chemicals [INDs/NDAs] and food additives, and as a clinical evaluator at the FDA.

Dr. Khalsa has published extensively in peer-reviewed journals and serves as a reviewer for many journals, including JAMA, CJAM, Virology, and others. He is also on the editorial boards of Journals of Addiction Medicine, Current Psychopharmacology, Research on HIV/AIDS and Palliative Care, and Frontiers of Neuroscience. He has served on numerous Federal and NIH-level committees, including the HHS Viral Hepatitis Implementation Group (VHIG), the National Commission on Digestive Diseases and its two sub-committees (Liver Research, Diabetes Research), the Federal Task Force on TB, the NIH Steering Committee on Centers for AIDS Research, and the Human Microbiome Workgroup.

Dr. Khalsa has received distinguished service awards from the FDA Commissioner, the Directors of NIH and NIDA, the Society of Neuro-Immune-Pharmacology (SNIP), Lifetime Achievement Awards from SNIP and the International Conference on Molecular Medicine (India) and MIT, India; a commendation from U.S. Congressman Elijah Cummings, Awards of Merit and Honorary Membership in the International Society of Addiction Medicine (ISAM), Distinguished Fellow (DFISAM), Honorary Membership in the Iceland Society of Addiction Medicine, recognition from the President of the American Society of Addiction Medicine (ASAM), a Certificate of Appreciation from the Office of the Assistant Secretary for Health (Drs. Howard Koh and Ron Valdiserri), DHHS, and a Lifetime Service Award from the Society of Nanotechnology and Personalized Medicine.

Dr. Khalsa holds a Ph.D. in Neuropsychopharmacology, a master’s degree in pharmacology/pharmacognosy (herbal pharmacology), bachelor’s degrees in chemistry/botany and pharmacy, and post-doctoral training in CNS/cardiovascular pharmacology at SK&F and environmental toxicology at Stanford Research Institute International.

Contact Information:

• Email: jag.khalsa@nih.gov
• Personal Email: jkhalsa@yahoo.com

DEPARTMENT OF PSYCHOLOGY, CURRY COLLEGE, MILTON, MA, USA
(Specialized in ADHD & Autism Spectrum Disorder – Research Interest: Neuroscience)

Dr. Edward Justin Modestino is a neuroscientist, professor, and licensed mental health counselor. He completed two postdoctoral fellowships in neuroimaging: one in psychiatry at the University of Virginia and one in neurology at Boston University. He is currently a Senior Lecturer of Psychology and Co-director of the EEG Lab at Curry College in Milton, MA. Additionally, he serves as a therapist in private practice at Stoughton Counseling, Inc. in Stoughton, MA.

Dr. Modestino’s research focuses on ADHD and related components, including addiction and Reward Deficiency Syndrome (RDS).

Professional Roles:

• Neuroscientist and Mental Health Counselor
• Senior Lecturer of Psychology and Co-director of EEG Lab at Curry College
  Curry College Profile
• Director of Brain & Behavior Lab
  Brain & Behavior Lab
• Licensed Mental Health Counselor at Stoughton Counseling, Inc.
  Stoughton Counseling Profile
• Associate Editor for the Journal of Addiction Science
• Editorial Board Member for Current Psychopharmacology
• Editorial Board Member for the Journal of Personalized Medicine
• Editorial Board Member of INNOSC Theranostics and Pharmacological Sciences (ITPS)

FOUNDER/PRESIDENT, GLOBAL GROWTH INSTITUTE, INC.; THE CHICAGO SCHOOL OF PROFESSIONAL PSYCHOLOGY; EMERITUS PROFESSOR AT CALIFORNIA STATE UNIVERSITY, LONG BEACH
(Author of “Intentional Parenting,” Hardcover – July 1, 2022, with Foojan Zeine and Eileen Manookian)
Research Interest: Neuroscience of Addiction & Psychology

Dr. Nicole Jafari holds a doctorate in education specializing in behavioral and developmental psychology. For the past twenty-one years, Dr. Jafari has taught various psychology and human development courses encompassing multidisciplinary and cross-cultural contexts. She is an Associate Professor at the Chicago School of Professional Psychology, Los Angeles campus, teaching doctoral students in the Applied Clinical Psychology department. Her research interests include cross-cultural and multidisciplinary emphasis, lifespan developmental challenges, parenting strategies, and the association between scientific and spiritual growth. Dr. Jafari has published and co-authored many research articles on children and adolescents and lifespan developmental topics in various highly regarded scientific and academic journals.

Additionally, she has authored several scholarly books with a global, cultural, and multidisciplinary perspective on human development. As an international public speaker, she addresses subjects related to human development (from prenatal to late adulthood), children, youths, and families in today’s multicultural and multi-contextual environment, covering issues such as mass media, globalization, cultural integration, and effective parenting. In her spare time, Dr. Jafari co-hosts several weekly radio, TV, and media broadcast programs on developmental, social, and psychological topics, including parenting, family, children, and adolescents.

In other capacities, Dr. Jafari has worked or is currently working with several prestigious organizations, including:

• Scientific Conference Co-chair & Researcher: Society of Brain Mapping and Therapeutics, a worldwide scientific entity instrumental in the global collaboration of high-caliber scientists in various scientific fields. SBMT
• Advisory Board Member: TREAT California, promoting safe, responsible, and ethical strategies for psychedelic medicine research and innovations. TREAT California
• Scientific Advisory Board Member: TRANSPLICEGEN, LLC, a leading organization in genetic testing and pre-addiction assessment.
• Founder and President: Cross-Cultural Research and Educational Institute (CREI), a 501(c)(3) non-profit organization that conducts global research, assessments, and educational seminars/workshops.
• Co-founder and CEO: Global Growth Institute, an organization dedicated to helping individuals, teams, and organizations through counseling, consulting, and coaching with a multicultural, multidisciplinary, and global perspective.

CELLULAR AND MOLECULAR RESEARCH CENTER, SCHOOL OF MEDICINE, GUILAN UNIVERSITY OF MEDICAL SCIENCES, RASHT, IRAN

Dr. Alireza Sharafshah is a board member at the Cellular and Molecular Research Center, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran. His research interest is in pharmacogenomics.

SENIOR RESEARCH SCIENTIST AT UNIVERSITY AT BUFFALO, THE STATE UNIVERSITY OF NEW YORK
ASSOCIATE PROFESSOR OF THE DEPARTMENT OF PHARMACOLOGY & TOXICOLOGY, JACOBS SCHOOL OF MEDICINE, UNIVERSITY AT BUFFALO
HONORARY PROFESSOR, ARIEL UNIVERSITY, ISRAEL

Dr. P. Anayotis K. Thanos is a Senior Research Scientist at the University at Buffalo, The State University of New York, and an Associate Professor in the Department of Pharmacology & Toxicology at the Jacobs School of Medicine, University at Buffalo. He also holds an honorary professorship at Ariel University, Israel.

Dr. Thanos performed the first-ever gene therapy with the DRD2 gene, demonstrating an extraordinary reduction in alcohol and cocaine intake in animals. He is the Director of the Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions at the Clinical Research Institute on Addictions.

Research Interests:

• Glucose Metabolism
• Behavioral Neuroscience
• Dopamine
• Neuropsychopharmacology
• Brain Mapping
• Functional Neuroimaging
• Neurobiology
• Genetics
• Exercise

MIDWEST SPINE AND BRAIN INSTITUTE AND HYPERCHARGE CLINICS

Dr. Daniel Sipple’s interests include medical-legal services, leading-edge research, innovative entrepreneurship, and national and global neuroscience policy. He founded Acies Medical and invented a life-saving needle.

Research Interests:

• Pain
• Addiction Liability
• Exercise with Oxygen Therapy
• Class IV Laser
• NanoVi Structured Water Therapy
• Photobiomodulation
• NuCalm

FULL PROFESSOR AND FORMER VICE PRESIDENT AND PROVOST, WESTERN UNIVERSITY OF HEALTH SCIENCES, POMONA, CALIFORNIA

Dr. David Baron is a Full Professor and former Vice President and Provost at Western University of Health Sciences, Pomona, California. He has also served in various roles at the Keck School of Medicine, including Vice Dean for Global Health, Professor of Psychiatry and Neurosurgery, Vice Chair of the Department of Psychiatry, and Chief of Service at Keck-USC Hospital. Additionally, he is the former Deputy Clinical Director of the National Institute of Mental Health (NIMH) and a former President of the American College of Neuropsychiatry. A former Olympian in swimming, Dr. Baron is now a member of the Olympic Committee Global.

Dr. Baron was named a National Fulbright Scholar in 2017-18 and conducted his research as Distinguished Chair in Brain Research at the University of Calgary. He is also the recipient of a Fulbright Specialist Award.

Research Interests:

• Sports Psychiatry and Addiction Liability
• Neurobiology
• Genetics
• Recovery Science

In conjunction with Dr. Kenneth Blum, Dr. Baron has published 103 articles listed on PubMed.

DEPARTMENT OF ORTHOPAEDICS, FUNDACIÓN UNIVERSITARIA SANITAS, BOGOTÁ, DC, COLOMBIA; DEPARTMENT OF ORTHOPEDICS, HOSPITAL UNIVERSITÁRIO GAFFRÉ E GUINLE, UNIVERSIDADE FEDERAL DO ESTADO DO RIO DE JANEIRO, BRAZIL; CENTER FOR ADVANCED SPINAL SURGERY OF SOUTHERN ARIZONA, TUCSON, UNITED STATES

Dr. Kai-Uwe Lewandrowski is a distinguished member of the National Academy of Medicine in both Colombia and Brazil. He is affiliated with several prestigious institutions, including the Department of Orthopaedics at Fundación Universitaria Sanitas in Bogotá, DC, Colombia; the Department of Orthopedics at Hospital Universitário Gaffré e Guinle, Universidade Federal do Estado do Rio de Janeiro, Brazil; and the Center for Advanced Spinal Surgery of Southern Arizona, Tucson, United States.

Dr. Lewandrowski’s research interests focus on pain and pharmacogenomics.

Dr. Hyla Cass is one of the nation’s foremost experts, authors, and speakers in the field of integrative medicine and psychiatry. Known as “the non-drug psychiatrist,” she is recognized for helping individuals withdraw from both psychiatric medication and substances of abuse using natural means, including hemp oil/CBD and other natural supplements.

Dr. Cass frequently appears as a guest on podcasts, summits, radio, television, and in national print media. She is also the author of several popular books, including: Natural Highs, 8 Weeks to Vibrant Health, Supplement Your Prescription: What Your Doctor Doesn’t Know About Nutrition, The Addicted Brain and How to Break Free, and Your Amazing Itty Bitty Guide to Cannabis.

A native of Toronto, Dr. Cass graduated from the University of Toronto School of Medicine, interned at Los Angeles County-USC Medical Center, and completed a psychiatric residency at Cedars-Sinai Medical Center/UCLA School of Medicine. She is a Diplomate of the American Board of Psychiatry and Neurology (ABPN) and of the American Board of Integrative Holistic Medicine (ABIHM). Based in Southern California, she has a limited virtual practice.